[1]
|
中国心血管健康与疾病报告2021概要[J]. 中国循环杂志, 2022, 37(6): 553-578.
|
[2]
|
潘杰, 刘来浩, 牟建伟. 肠道菌群与人类健康研究进展[J]. 山东师范大学学报(自然科学版), 2021, 36(4): 337-365.
|
[3]
|
Tang, W.H., Kitai, T. and Hazen, S.L. (2017) Gut Microbiota in Cardiovascular Health and Disease. Circulation Research, 120, 1183-1196. https://doi.org/10.1161/CIRCRESAHA.117.309715
|
[4]
|
王亚丽, 程艳丽, 商丽华. 肠道菌群在冠心病发病机制中的研究进展[J]. 中国研究型医院, 2023, 10(1): 59-62.
|
[5]
|
杨光, 何浩强, 陈光, 王阶. 中药调节肠道菌群干预冠心病及其危险因素的研究进展[J]. 中国中药杂志, 2020, 45(1): 29-36.
|
[6]
|
Onal, E.M., Afsar, B., Covic, A., Vaziri, N.D. and Kanbay, M. (2019) Gut Microbiota and Inflammation in Chronic Kidney Disease and Their roles in the Development of Cardiovascular Disease. Hypertension Research, 42, 123-140.
https://doi.org/10.1038/s41440-018-0144-z
|
[7]
|
高丽娟, 刘立, 李龙龙, 周亚兰, 吕若琳, 周亚楠, 黄生辉. 基于微生物-肠-脑轴的脾胃为后天之本理论探讨[J]. 时珍国医国药, 2019, 30(6): 1449-1450.
|
[8]
|
黄湘龙. 冠心病中医证候特征演变规律及其化验指标相关性[D]: [硕士学位论文]. 天津: 天津中医药大学, 2022.
|
[9]
|
杨果. 中医健康管理模式下冠心病心绞痛中医证素演变特点的观察性研究[D]: [硕士学位论文]. 乌鲁木齐: 新疆医科大学, 2022.
|
[10]
|
石伊娜, 陈金锋, 杨波, 等. 雷忠义国医大师论治冠心病痰瘀互结致气虚证的探究[J]. 辽宁中医药大学学报, 2023: 1-15.
|
[11]
|
Wu, K., Yuan, Y., Yu, H., Dai, X., Wang, S., Sun, Z., Wang, F., Fei, H., Lin, Q., Jiang, H. and Chen, T. (2020) The Gut Microbial Metabolite Trimethylamine N-Oxide Aggravates GVHD by Inducing M1 Macrophage Polarization in Mice. Blood, 136, 501-515. https://doi.org/10.1182/blood.2019003990
|
[12]
|
Witkowski, M., Weeks, T.L. and Hazen, S.L. (2020) Gut Microbiota and Cardiovascular Disease. Circulation Research, 127, 553-570. https://doi.org/10.1161/CIRCRESAHA.120.316242
|
[13]
|
孙东文, 姜文君, 邰晓峰, 等. 中西医对肠道菌群与冠心病关系的研究及治疗进展[J]. 吉林中医药, 2023, 43(12): 1488-1492.
|
[14]
|
胡海兵, 崔立, 郭靓骅, 王春艳, 华修国, 余强, 尹桂芝. 基于高通量测序技术的冠心病患者肠道菌群多样性研究[J]. 上海交通大学学报(农业科学版), 2016, 34(2): 1-11+19.
|
[15]
|
陈扬平, 陈维玉, 张秋霞, 修建成. 不同临床分型冠心病患者的肠道菌群多样性分析[J]. 实用医学杂志, 2020, 36(13): 1754-1758.
|
[16]
|
Liu, H., Zhuang, J., Tang, P., Li, J., Xiong, X. and Deng, H. (2020) The Role of the Gut Microbiota in Coronary Heart Disease. Current Atherosclerosis Reports, 22, Arti-cle No. 77. https://doi.org/10.1007/s11883-020-00892-2
|
[17]
|
Liu, H., Chen, X., Hu, X., Niu, H., Tian, R., Wang, H., Pang, H., et al. (2019) Alterations in the Gut Microbiome and Metabolism with Coronary Artery Disease Severity. Microbiome, 7, Article No. 68.
https://doi.org/10.1186/s40168-019-0683-9
|
[18]
|
Warrier, M., Shih, D.M., Burrows, A.C., Ferguson, D., Gromovsky, A.D., Brown, A.L., Marshall, S., et al. (2015) The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance. Cell Reports, 10, 326-338. https://doi.org/10.1016/j.celrep.2014.12.036
|
[19]
|
Zhou, X., Li, J., Guo, J., Geng, B., Ji, W., Zhao, Q., et al. (2018) Gut-Dependent Microbial Translocation Induces Inflammation and Cardiovascular Events after ST-Elevation Myocardial Infarction. Microbiome, 6, Article No. 66.
https://doi.org/10.1186/s40168-018-0441-4
|
[20]
|
Tang, W.H.W., Li, D.Y. and Hazen, S.L. (2019) Dietary Metabo-lism, the Gut Microbiome, and Heart Failure. Nature Reviews Cardiology, 16, 137-154. https://doi.org/10.1038/s41569-018-0108-7
|
[21]
|
罗雅亭, 程如越, 梁惠菁, 王家妮, 沈曦, 何方. 高脂饮食对小鼠糖、脂代谢及肠道菌群结构的影响[J]. 营养学报, 2020, 42(5): 458-464.
|
[22]
|
李子芃, 陈巍, 田海. 肠道菌群及其代谢产物在冠心病中作用的研究进展[J]. 中国胸心血管外科临床杂志, 2023, 30(5): 761-765.
|
[23]
|
Heianza, Y., Ma, W., Di Donato, J.A., Sun, Q., Rimm, E.B., Hu, F.B., Rexrode, K.M., Manson, J.E. and Qi, L. (2020) Long-Term Changes in Gut Microbial Metabolite Trimethylamine N-Oxide and Coronary Heart Disease Risk. Journal of the American College of Cardiology, 75, 763-772. https://doi.org/10.1016/j.jacc.2019.11.060
|
[24]
|
Senthong, V., Wang, Z., Li, X.S., Fan, Y., Wu, Y., Tang, W.H. and Hazen, S.L. (2016) Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intes-tinal Microbiota in a COURAGE-Like Patient Cohort. Journal of the American Heart Association, 5, e002816.
https://doi.org/10.1161/JAHA.115.002816
|
[25]
|
Yao, M.E., Liao, P.D., Zhao, X.J. and Wang, L. (2020) Trime-thylamine-N-Oxide Has Prognostic Value in Coronary Heart Disease: A Meta-Analysis and Dose-Response Analysis. BMC Cardiovascular Disorders, 20, Article No. 7.
https://doi.org/10.1186/s12872-019-01310-5
|
[26]
|
Yu, D., Shu, X.O., Rivera, E.S., Zhang, X., Cai, Q., Calcutt, M.W., et al. (2019) Urinary Levels of Trimethylamine- N-Oxide and Incident Coronary Heart Disease: A Prospective Investigation among Urban Chinese Adults. Journal of the American Heart Association, 8, e010606. https://doi.org/10.1161/JAHA.118.010606
|
[27]
|
姜惠卿, 于良生, 赵秀姿. 补中益气汤治疗冠心病104例分析[J]. 齐鲁医学杂志, 2004(4): 348.
|
[28]
|
姜华, 杨景明. 参苓白术散对脾虚小鼠肠道功能的影响及其机制研究[J]. 亚太传统医药, 2016, 12(7): 16-17.
|
[29]
|
黄文武, 彭颖, 王梦月, 彭崇胜, 李晓波. 四君子汤及其单味药水煎液对脾虚大鼠肠道菌群的调节作用[J]. 中国实验方剂学杂志, 2019, 25(11): 8-15.
|
[30]
|
孙巍. 浅谈补中益气汤在促进肠道益生菌生长中的作用[J]. 求医问药(下半月), 2013, 11(9): 137-138.
|
[31]
|
汤燕醒. 加味归脾汤治疗气血两虚型冠心病40例疗效观察[J]. 中国实用医药, 2017, 12(19): 112-114.
|